Dupont and Pfizer to Receive CPR Institute's 2009 Corporate Leadership Award

The International Institute for Conflict Prevention & Resolution (CPR Institute), a nonprofit alliance of global corporations, law firms, scholars, and public institutions dedicated to the principles of commercial conflict prevention and alternative dispute resolution (ADR), announces the recipients of the organization’s 2009 Corporate Leadership Award.  For the first time, CPR is honoring two corporate leaders: Thomas L. Sager, Senior Vice President & General Counsel of DuPont, and Amy W. Schulman, Senior Vice President & General Counsel of Pfizer will be recognized, along with their companies, for their dedication to the field of ADR on November 3 in New York City.


The 2009 Corporate Leadership Award will be presented at a black tie dinner at Cipriani 42nd Street in New York City.  The event will draw approximately 500 attendees representing the top corporations, law firms, scholars, and public institutions in the country.  The funds raised by the Corporate Leadership Award Dinner support CPR Institute’s educational, research and public policy programs.  For more information about the Dinner or to reserve a table, visit www.cpradr.org.

Each year, the CPR Institute honors a corporation that has demonstrated leadership and commitment to the principles of conflict management and resolution and has institutionalized alternative dispute resolution principles into their corporate and industry culture. Previous honorees include Johnson & Johnson, General Electric, Ernst & Young, ConocoPhillips, and Microsoft.

As two of the founding members of the CPR Institute, DuPont and Pfizer have been pioneers in the corporate legal community’s commitment to conflict resolution practices and principles.  They have used alternative dispute resolution on a variety of litigation matters, as well as using preventive measures, and have been strong advocates for ADR use within their respective industries.

 “For their corporate leadership and commitment to principled conflict management and resolution, the CPR Institute is proud to honor DuPont and Pfizer,” said Kathleen A. Bryan, President and CEO of the CPR Institute.  “Under the superior leadership of Sager and Schulman, respectively, they have set a successful benchmark against which all companies’ legal departments should be measured.”

DuPont joined CPR in 1980 and was a leader in the use of the CPR Chemical Industry Dispute Resolution Commitment to consider ADR in intra-industry disputes. Notably, the DuPont Legal Model incorporates early case assessment and mediation as core strategies.  Mr. Sager currently serves as co-chair of CPR’s National Task Force on Diversity in ADR. 

A member of CPR since 1984, Pfizer has been a national ADR leader, spearheading initiatives resolving class actions with innovative settlements in the 1990’s, and, more recently, providing a forum for the National Task Force on Diversity in ADR to meet, develop, and advance its essential mission. A longstanding champion of alternative dispute resolution, Ms. Schulman continues Pfizer’s dedication to the principles of ADR through her leadership. 

DuPont and Pfizer have been loyal sponsors of CPR’s public policy projects and its National Task Force on Diversity in ADR.  They have further demonstrated their leadership by sponsoring CPR’s international work in Europe and China. In 1984, both corporations signed CPR’s Corporate Policy Statement on Alternatives to Litigation©. The “ADR Pledge” is a statement of policy aimed at encouraging greater use of flexible, creative and constructive approaches in resolving business-related disputes. It promotes systematic, early resolution and establishes a flexible framework for helping to resolve complex multi-party disputes

About DuPont
DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation. Learn more at www.dupont.com.

About Thomas Sager
Thomas Sager started his career with DuPont in August 1976 as an attorney in the labor and securities group. He helped pioneer the DuPont Convergence and Law Firm Partnering Program and continues to have oversight responsibility. Through his leadership, this program has become a benchmark in the industry and has received national acclaim for its innovative approach to the business of practicing law. He also was recently recognized as one of the 20 Most Influential General Counsel in America by The National Law Journal.

About Pfizer
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life.  We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals.  Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products.  Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world’s leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world.  For more than 150 years, Pfizer has worked to make a difference for all who rely on us.  To learn more about our commitments, please visit us at www.pfizer.com

About Amy Schulman
Amy W. Schulman leads Pfizer’s worldwide Legal Division and is responsible for a wide range of legal and regulatory areas, including intellectual property, litigation, regulatory law and compliance, global security, licensing and acquisitions. Before joining Pfizer in June 2008, Ms. Schulman was a partner at DLA Piper, an international business law firm, where she was a member of the firm’s Global Board and its Executive and Policy Committees. Ms. Schulman also was recognized as one of the 20 Most Influential General Counsel in America by The National Law Journal and was selected by Forbes magazine as one of The World’s 100 Most Powerful Women in 2009.

About the CPR Institute
As a think tank and educational not-for-profit organization, the CPR Institute provides thought leadership and innovation as the global resource for conflict management and resolution of complex business-related disputes.  Our wealth of intellectual property and published material has educated and motivated General Counsel and their law firms around the world toward an increased reliance on alternative forms of dispute resolution rather than litigation. CPR Institute’s membership is comprised of general counsel and senior lawyers of Fortune 1,000 organizations, partners in the top law firms around the world, as well as leading judges, government officials, neutrals, and academicians. Our proprietary panel of esteemed arbitrators and mediators has provided resolutions in thousands of cases, with billions of dollars at issue, worldwide. For more information, please visit www.cpradr.org.

###

 Download a PDF of this Press Release here